Cargando…

Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study

BACKGROUND: Supervised injection facilities (SIFs) are legally sanctioned environments for people to inject drugs under medical supervision. SIFs currently operate in ten countries, but to date, no SIF has been opened in the USA. In light of increasing overdose mortality in the USA, this study evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouvier, Benjamin A., Elston, Beth, Hadland, Scott E., Green, Traci C., Marshall, Brandon D. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319157/
https://www.ncbi.nlm.nih.gov/pubmed/28219388
http://dx.doi.org/10.1186/s12954-017-0139-0
_version_ 1782509330556256256
author Bouvier, Benjamin A.
Elston, Beth
Hadland, Scott E.
Green, Traci C.
Marshall, Brandon D. L.
author_facet Bouvier, Benjamin A.
Elston, Beth
Hadland, Scott E.
Green, Traci C.
Marshall, Brandon D. L.
author_sort Bouvier, Benjamin A.
collection PubMed
description BACKGROUND: Supervised injection facilities (SIFs) are legally sanctioned environments for people to inject drugs under medical supervision. SIFs currently operate in ten countries, but to date, no SIF has been opened in the USA. In light of increasing overdose mortality in the USA, this study evaluated willingness to use a SIF among youth who report non-medical prescription opioid (NMPO) use. METHODS: Between January 2015 and February 2016, youth with recent NMPO use were recruited to participate in the Rhode Island Young Adult Prescription Drug Study (RAPiDS). We explored factors associated with willingness to use a SIF among participants who had injected drugs or were at risk of initiating injection drug use (defined as having a sex partner who injects drugs or having a close friend who injects). RESULTS: Among 54 eligible participants, the median age was 26 (IQR = 24–28), 70.4% were male, and 74.1% were white. Among all participants, when asked if they would use a SIF, 63.0% answered “Yes”, 31.5% answered “No”, and 5.6% were unsure. Among the 31 participants reporting injection drug use in the last six months, 27 (87.1%) reported willingness to use a SIF; 15 of the 19 (78.9%) who injected less than daily reported willingness, while all 12 (100.0%) of the participants who injected daily reported willingness. Compared to participants who were unwilling or were unsure, participants willing to use a SIF were also more likely to have been homeless in the last six months, have accidentally overdosed, have used heroin, have used fentanyl non-medically, and typically use prescription opioids alone. CONCLUSIONS: Among young adults who use prescription opioids non-medically and inject drugs or are at risk of initiating injection drug use, more than six in ten reported willingness to use a SIF. Established risk factors for overdose, including homelessness, history of overdose, daily injection drug use, heroin use, and fentanyl misuse, were associated with higher SIF acceptability, indicating that young people at the highest risk of overdose might ultimately be the same individuals to use the facility. Supervised injection facilities merit consideration to reduce overdose mortality in the USA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12954-017-0139-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5319157
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53191572017-02-24 Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study Bouvier, Benjamin A. Elston, Beth Hadland, Scott E. Green, Traci C. Marshall, Brandon D. L. Harm Reduct J Research BACKGROUND: Supervised injection facilities (SIFs) are legally sanctioned environments for people to inject drugs under medical supervision. SIFs currently operate in ten countries, but to date, no SIF has been opened in the USA. In light of increasing overdose mortality in the USA, this study evaluated willingness to use a SIF among youth who report non-medical prescription opioid (NMPO) use. METHODS: Between January 2015 and February 2016, youth with recent NMPO use were recruited to participate in the Rhode Island Young Adult Prescription Drug Study (RAPiDS). We explored factors associated with willingness to use a SIF among participants who had injected drugs or were at risk of initiating injection drug use (defined as having a sex partner who injects drugs or having a close friend who injects). RESULTS: Among 54 eligible participants, the median age was 26 (IQR = 24–28), 70.4% were male, and 74.1% were white. Among all participants, when asked if they would use a SIF, 63.0% answered “Yes”, 31.5% answered “No”, and 5.6% were unsure. Among the 31 participants reporting injection drug use in the last six months, 27 (87.1%) reported willingness to use a SIF; 15 of the 19 (78.9%) who injected less than daily reported willingness, while all 12 (100.0%) of the participants who injected daily reported willingness. Compared to participants who were unwilling or were unsure, participants willing to use a SIF were also more likely to have been homeless in the last six months, have accidentally overdosed, have used heroin, have used fentanyl non-medically, and typically use prescription opioids alone. CONCLUSIONS: Among young adults who use prescription opioids non-medically and inject drugs or are at risk of initiating injection drug use, more than six in ten reported willingness to use a SIF. Established risk factors for overdose, including homelessness, history of overdose, daily injection drug use, heroin use, and fentanyl misuse, were associated with higher SIF acceptability, indicating that young people at the highest risk of overdose might ultimately be the same individuals to use the facility. Supervised injection facilities merit consideration to reduce overdose mortality in the USA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12954-017-0139-0) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-20 /pmc/articles/PMC5319157/ /pubmed/28219388 http://dx.doi.org/10.1186/s12954-017-0139-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Bouvier, Benjamin A.
Elston, Beth
Hadland, Scott E.
Green, Traci C.
Marshall, Brandon D. L.
Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study
title Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study
title_full Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study
title_fullStr Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study
title_full_unstemmed Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study
title_short Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study
title_sort willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319157/
https://www.ncbi.nlm.nih.gov/pubmed/28219388
http://dx.doi.org/10.1186/s12954-017-0139-0
work_keys_str_mv AT bouvierbenjamina willingnesstouseasupervisedinjectionfacilityamongyoungadultswhouseprescriptionopioidsnonmedicallyacrosssectionalstudy
AT elstonbeth willingnesstouseasupervisedinjectionfacilityamongyoungadultswhouseprescriptionopioidsnonmedicallyacrosssectionalstudy
AT hadlandscotte willingnesstouseasupervisedinjectionfacilityamongyoungadultswhouseprescriptionopioidsnonmedicallyacrosssectionalstudy
AT greentracic willingnesstouseasupervisedinjectionfacilityamongyoungadultswhouseprescriptionopioidsnonmedicallyacrosssectionalstudy
AT marshallbrandondl willingnesstouseasupervisedinjectionfacilityamongyoungadultswhouseprescriptionopioidsnonmedicallyacrosssectionalstudy